CLSI eNews - 1 February 2007  (Plain Text Version)

Return to Graphical Version | Search back issues | Print all articles

In this issue:
Note on printing single articles: Each selected individual article will appear at the bottom of this screen...please scroll down to view/print the selected article.
 
News
 Executive Vice President's Message
 Antibiotic susceptibility testing matters
 Announcement: New 2007 CLSI Catalog
 Press Releases
Standards Status
 Vote and Deadlines
 Recently Approved Documents
Events and Exhibits
 Upcoming Events
 Upcoming Presentations
 CLSI Meetings Calendar
Participate in CLSI
 Volunteer
 New and Sustaining Members
 Update Your Subscription


Vote and Deadlines

User Protocol for Evaluation of Qualitative Test Performance (EP12-A2)

CLSI submits the following for vote as a candidate-for-advancement consensus document.  The document and ballot is available to delegates and alternates of Active and Associate Active member organizations through CLSI Forums.  

EP12-A2User Protocol for Evaluation of Qualitative Test Performance; Approved Guideline—Second Edition This document provides a consistent approach for protocol design and data analysis when evaluating qualitative diagnostic tests. Guidance is provided for both precision and method-comparison studies. The deadline for the completed ballot for EP12-A2 to be received at the CLSI offices is 2 April 2007.


Under our Administrative Procedures, a CLSI document approved by the area committee at the first level of the consensus process is submitted to delegates as a “candidate-for-advancement” consensus document. This begins the voting and approval period by the delegates.

As a delegate, your vote is to affirm (or reject) the document for advancement as a CLSI document. Please send your completed ballot to the CLSI offices by the above deadline.

In the consensus process, comments are invited at each publication stage. In each edition, the responsible committee includes a summary of comments on the prior edition and its responses to them. Any comments received on a candidate-for-advancement consensus document as a result of delegate voting and consensus review will be addressed by the committee during the document’s advancement.

Find out more about Active and Associate Active membership.


For more information or to contact us directly, please visit www.clsi.org l ©2006 Clinical and Laboratory Standards Institute